INFLUENZA G1 mHA

· Janssen Vaccines & Prevention B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INFLUENZA G1 mHA, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults [Phase 1, Phase 2]

See pricing